| scholarly article | Q13442814 |
| P2093 | author name string | Roger J Hajjar | |
| Djamel Lebeche | |||
| Susumu Sakata | |||
| Federica del Monte | |||
| Elie R Chemaly | |||
| Li Fan Liang | |||
| Naoya Sakata | |||
| Yuri Sakata | |||
| Noboru Konishi | |||
| Miyako Takaki | |||
| Prabhu Padmanabhan | |||
| P2860 | cites work | Altered calcium handling in experimental pressure-overload hypertrophy in the ferret | Q69979818 |
| Alterations of Sarcoplasmic Reticulum Proteins in Failing Human Dilated Cardiomyopathy | Q71974451 | ||
| Characteristics of diabetes, blood pressure, and cardiac and renal complications in Otsuka Long-Evans Tokushima Fatty rats | Q73115380 | ||
| Upregulation of Na(+)/Ca(2+) exchanger expression and function in an arrhythmogenic rabbit model of heart failure | Q73204498 | ||
| Alteration in left ventricular diastolic filling and accumulation of myocardial collagen at insulin-resistant prediabetic stage of a type II diabetic rat model | Q73492545 | ||
| Angiotensin blockade improves cardiac and renal complications of type II diabetic rats | Q73879432 | ||
| Cardiac Na/Ca exchange function in rabbit, mouse and man: what's the difference? | Q78049992 | ||
| Na/Ca exchange in heart failure: contractile dysfunction and arrhythmogenesis | Q78719599 | ||
| Restoration of contractile function in isolated cardiomyocytes from failing human hearts by gene transfer of SERCA2a | Q22010899 | ||
| Molecular basis of cardiac performance. Plasticity of the myocardium generated through protein isoform switches | Q24621025 | ||
| Calcium fluxes involved in control of cardiac myocyte contraction | Q28144050 | ||
| FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death | Q28183817 | ||
| Cardiac excitation-contraction coupling | Q28216347 | ||
| Cardiac adenoviral S100A1 gene delivery rescues failing myocardium | Q28296403 | ||
| Improvement in survival and cardiac metabolism after gene transfer of sarcoplasmic reticulum Ca(2+)-ATPase in a rat model of heart failure | Q28354203 | ||
| Prospects for gene therapy for heart failure | Q33881236 | ||
| In vivo ventricular gene delivery of a beta-adrenergic receptor kinase inhibitor to the failing heart reverses cardiac dysfunction | Q33936885 | ||
| Myofilament calcium regulation in human myocardium | Q34074806 | ||
| Targeting phospholamban by gene transfer in human heart failure | Q34074819 | ||
| Diabetes and atherosclerosis: epidemiology, pathophysiology, and management | Q34646074 | ||
| Clinical use of inotropic therapy for heart failure: looking backward or forward? Part II: chronic inotropic therapy | Q35186772 | ||
| Left ventricular mechanoenergetics in small animals | Q35947413 | ||
| Abrogation of ventricular arrhythmias in a model of ischemia and reperfusion by targeting myocardial calcium cycling | Q37682472 | ||
| Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain | Q43619196 | ||
| Left ventricular diastolic dysfunction in type 2 diabetes mellitus model rats | Q43826644 | ||
| Progression of heart failure: is protein kinase a hyperphosphorylation of the ryanodine receptor a contributing factor? | Q43862764 | ||
| Overexpression of the sarcoplasmic reticulum Ca(2+)-ATPase improves myocardial contractility in diabetic cardiomyopathy | Q43935483 | ||
| beta2 adrenoceptor gene therapy ameliorates left ventricular dysfunction following cardiac surgery | Q45879401 | ||
| Novel technique of aortic banding followed by gene transfer during hypertrophy and heart failure | Q45885002 | ||
| The functional effect of adenoviral Na+/Ca2+ exchanger overexpression in rabbit myocytes depends on the activity of the Na+/K+-ATPase | Q48746169 | ||
| Relationship between Na+-Ca2+-exchanger protein levels and diastolic function of failing human myocardium | Q48749719 | ||
| Increased oxygen cost of contractility in stunned myocardium of dog | Q68033346 | ||
| Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure | Q69122833 | ||
| P433 | issue | 5 | |
| P921 | main subject | cardiomyopathy | Q847583 |
| type 2 diabetes | Q3025883 | ||
| P304 | page(s) | 987-996 | |
| P577 | publication date | 2006-02-24 | |
| P1433 | published in | Molecular Therapy | Q15762400 |
| P1476 | title | Mechanical and metabolic rescue in a type II diabetes model of cardiomyopathy by targeted gene transfer | |
| P478 | volume | 13 |
| Q57799740 | A role for calcium in resistin transcriptional activation in diabetic hearts |
| Q35129485 | A systematic review of fetal genes as biomarkers of cardiac hypertrophy in rodent models of diabetes. |
| Q37766138 | Advances in gene-based therapy for heart failure |
| Q39493909 | Ca2+ cycling and new therapeutic approaches for heart failure |
| Q51414827 | Cardiac activation heat remains inversely dependent on temperature over the range 27-37°C. |
| Q27002459 | Cardiac dysfunction and oxidative stress in the metabolic syndrome: an update on antioxidant therapies |
| Q36977176 | Conditional increase in SERCA2a protein is able to reverse contractile dysfunction and abnormal calcium flux in established diabetic cardiomyopathy |
| Q36174452 | Diabetic cardiomyopathy: is resistin a culprit? |
| Q28395852 | Diabetic cardiomyopathy: signaling defects and therapeutic approaches |
| Q46730696 | Earlier onset of diabesity-Induced adverse cardiac remodeling in female compared to male mice |
| Q44087330 | Exercise training prevents the development of cardiac dysfunction in the low-dose streptozotocin diabetic rats fed a high-fat diet. |
| Q33489603 | Gene remodeling in type 2 diabetic cardiomyopathy and its phenotypic rescue with SERCA2a |
| Q45857145 | Gene therapy for diabetic cardiomyopathy: a new approach for a difficult problem |
| Q57823807 | Human Cardiac Gene Therapy |
| Q46291758 | Increased expression of SERCA in the hearts of transgenic mice results in increased oxidation of glucose |
| Q34279229 | Increased myocardial SERCA expression in early type 2 diabetes mellitus is insulin dependent: In vivo and in vitro data |
| Q37278004 | Interplay between impaired calcium regulation and insulin signaling abnormalities in diabetic cardiomyopathy |
| Q43110528 | Long-term cardiac-targeted RNA interference for the treatment of heart failure restores cardiac function and reduces pathological hypertrophy |
| Q36699924 | Mechanisms of impaired calcium handling underlying subclinical diastolic dysfunction in diabetes |
| Q37691385 | Overexpression of Sarcoendoplasmic Reticulum Calcium ATPase 2a Promotes Cardiac Sympathetic Neurotransmission via Abnormal Endoplasmic Reticulum and Mitochondria Ca2+ Regulation. |
| Q36228624 | Phospholamban Ablation Using CRISPR/Cas9 System Improves Mortality in a Murine Heart Failure Model |
| Q46921446 | Preservation of mechanical and energetic function after adenoviral gene transfer in normal rat hearts |
| Q35933316 | Restoration of mechanical and energetic function in failing aortic-banded rat hearts by gene transfer of calcium cycling proteins |
| Q34328371 | Role of ER stress in ventricular contractile dysfunction in type 2 diabetes |
| Q37418216 | SERCA2a gene therapy in heart failure: an anti-arrhythmic positive inotrope. |
| Q34025110 | SERCA2a gene transfer enhances eNOS expression and activity in endothelial cells |
| Q37676218 | Sarcoplasmic reticulum Ca(2+) ATPase as a therapeutic target for heart failure |
| Q36650350 | Small Molecular Allosteric Activator of the Sarco/Endoplasmic Reticulum Ca2+-ATPase (SERCA) Attenuates Diabetes and Metabolic Disorders |
| Q53580927 | Targeted gene transfer increases contractility and decreases oxygen cost of contractility in normal rat hearts. |
| Q37229784 | The cardiac sarcoplasmic/endoplasmic reticulum calcium ATPase: a potent target for cardiovascular diseases |
| Q47319449 | Transcoronary gene transfer of SERCA2a increases coronary blood flow and decreases cardiomyocyte size in a type 2 diabetic rat model |
Search more.